We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.3B
AUM Growth
+$1.54B
(+10%)
Cap. Flow
+$794M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
1,104
New
170
Increased
359
Reduced
380
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$274M |
| 2 |
General Motors
GM
|
+$175M |
| 3 |
Cigna
CI
|
+$139M |
| 4 |
Ford
F
|
+$133M |
| 5 |
Adobe
ADBE
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$193M |
| 2 |
Tesla
TSLA
|
+$181M |
| 3 |
Palo Alto Networks
PANW
|
+$164M |
| 4 |
Microsoft
MSFT
|
+$98.7M |
| 5 |
Cardinal Health
CAH
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.57% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Financials | 12.35% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Johnson & Johnson
JNJ
$640B
| $602K | ﹤0.01% |
3,884
-5,463
| -58% | -$882K |
|
777
Precision BioSciences
DTIL
$178M
| $593K | ﹤0.01% |
+26,230
| New | +$864K |
|
|
VGR
778
DELISTED
Vector Group Ltd.
VGR
| $590K | ﹤0.01% |
49,156
-619,077
| -93% | -$7.81M |
|
779
HBT Financial
HBT
$1.33B
| $589K | ﹤0.01% |
29,852
-5,240
| -15% | -$110K |
|
780
Ouster
OUST
$2.11B
| $588K | ﹤0.01% |
+70,218
| New | +$815K |
|
781
BrightView Holdings
BV
$1.24B
| $586K | ﹤0.01% |
104,250
+34,507
| +49% | +$233K |
|
782
Arhaus
ARHS
$1.07B
| $585K | ﹤0.01% |
+70,560
| New | +$852K |
|
783
Coursera
COUR
$1.77B
| $579K | ﹤0.01% |
+50,261
| New | +$651K |
|
784
GXO Logistics
GXO
$5.93B
| $574K | ﹤0.01% |
11,372
-28,579
| -72% | -$1.42M |
|
785
Regency Centers
REG
$14.9B
| $571K | ﹤0.01% |
+9,338
| New | +$587K |
|
786
SmartFinancial
SMBK
$906M
| $571K | ﹤0.01% |
24,687
-11,863
| -32% | -$309K |
|
787
BlueLinx
BXC
$430M
| $568K | ﹤0.01% |
8,361
| – | – |
|
788
Ceco Environmental
CECO
$3.49B
| $567K | ﹤0.01% |
40,498
-13,528
| -25% | -$191K |
|
789
Procept Biorobotics
PRCT
$1.02B
| $556K | ﹤0.01% |
19,582
-9,525
| -33% | -$336K |
|
790
Nasdaq
NDAQ
$53.4B
| $554K | ﹤0.01% |
10,142
-18,779
| -65% | -$1.09M |
|
|
LONA
791
LeonaBio Inc
LONA
$66.1M
| $553K | ﹤0.01% |
22,108
-3,162
| -13% | -$102K |
|
|
KALV
792
DELISTED
KalVista Pharmaceuticals
KALV
| $548K | ﹤0.01% |
+69,762
| New | +$521K |
|
|
HES
793
DELISTED
Hess
HES
| $538K | ﹤0.01% |
+4,065
| New | +$566K |
|
|
CELL
794
DELISTED
PhenomeX Inc. Common Stock
CELL
| $529K | ﹤0.01% |
455,922
-891,152
| -66% | -$1.63M |
|
795
Alpha and Omega Semiconductor
AOSL
$829M
| $525K | ﹤0.01% |
19,476
| – | – |
|
796
Marriott Vacations Worldwide
VAC
$3.53B
| $521K | ﹤0.01% |
+3,866
| New | +$574K |
|
797
Lazard
LAZ
$4B
| $516K | ﹤0.01% |
+15,596
| New | +$575K |
|
798
Primis Financial Corp
FRST
$399M
| $515K | ﹤0.01% |
53,515
-89
| -0.2% | -$1.01K |
|
799
Superior Group of Companies
SGC
$199M
| $512K | ﹤0.01% |
65,107
-20,171
| -24% | -$217K |
|
800
Flexsteel Industries
FLXS
$307M
| $507K | ﹤0.01% |
26,314
-11,328
| -30% | -$219K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2023 Portfolio in Review
As of Q1 2023, Jacobs Levy Equity Management held 1,104 positions worth $16.3B, up 10% from $14.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management deployed $794M of net new capital in Q1 2023, opening 170 new positions and adding to 359 existing holdings. Its largest new stake was Cigna: 475,901 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $193M trimmed.
- Jacobs Levy Equity Management's largest Q1 2023 buy was Cigna: 475,901 shares worth $122M.
- Jacobs Levy Equity Management added most to Apple in Q1 2023, an estimated $274M increase.
- Jacobs Levy Equity Management's biggest Q1 2023 reduction was Humana, cutting an estimated $193M.
- Jacobs Levy Equity Management fully exited PayPal in Q1 2023, selling an estimated $66.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $16.3B portfolio in Q1 2023.
- Jacobs Levy Equity Management opened 170 new positions and closed 160 in Q1 2023.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $16.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.